학술논문
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors
Document Type
Article
Author
Source
In: European Journal of Medical Research . (European Journal of Medical Research, December 2022, 27(1))
Subject
Language
English
ISSN
2047783X
09492321
09492321